- Home
- ROIV vs DBX Comparison
ROIV vs DBX Comparison
Compare ROIV & DBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | DBX |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 6.8B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ROIV | DBX |
|---|---|---|
| Price | $21.66 | $27.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 7 |
| Target Price | $24.31 | ★ $31.17 |
| AVG Volume (30 Days) | ★ 8.2M | 3.7M |
| Earning Date | 02-09-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.55 |
| EPS | N/A | ★ 1.67 |
| Revenue | $20,329,000.00 | ★ $2,528,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $741.42 | N/A |
| P/E Ratio | ★ N/A | $16.77 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $24.42 |
| 52 Week High | $23.47 | $33.33 |
Technical Indicators
Market Signals| Indicator | ROIV | DBX |
|---|---|---|
| Relative Strength Index (RSI) | 52.70 | 41.71 |
| Support Level | $21.60 | $27.78 |
| Resistance Level | $22.72 | $28.28 |
| Average True Range (ATR) | 0.83 | 0.81 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 45.58 | 40.15 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About DBX Dropbox Inc.
Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.